Opioid Rapid Response System: Naloxone Training in Communities
NCT06238128 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 773
Last updated 2026-01-23
Summary
The pervasive impact of the opioid epidemic has touched all layers of society for the past two decades, resulting in over 115 deaths daily and imposing annual costs of $78.5 billion. Responding swiftly to overdoses, akin to various medical emergencies, poses a significant challenge, particularly in geographically dispersed rural areas and densely populated urban settings. Effectively delivering the life-saving drug naloxone, which counteracts the effects of overdoses, necessitates a well-coordinated and cost-efficient response system.
Simply opting for widespread distribution of naloxone, even with citizen involvement, proves to be a financially burdensome approach when compared to more targeted strategies. Moreover, obstacles such as limited access, inadequate or unavailable naloxone training, and delayed response times from emergency responders compound the problem. Addressing these issues, the proposed Opioid Rapid Response System (ORRS) project seeks to advance prevention science by adopting an innovative approach that incorporates technology and contemporary communication theory.
The primary objective of the ORRS project is to mitigate opioid overdose deaths by enlisting and training citizens to administer naloxone in response to such events. Leveraging the PulsePoint health app, which connects citizens to cardiac events, the ORRS project will extend its capabilities to respond to overdose incidents. This initiative involves comprehensive development of ORRS, followed by a randomized clinical trial on a national scale to assess its effectiveness. The study aims to contribute to both prevention and implementation science by identifying optimal recruitment strategies and testing a model of online training. In pursuit of these objectives, the study is guided by the following Specific Aims:
SA 1: Refine and complete the development of ORRS. SA 2: Conduct a randomized clinical trial to evaluate the effectiveness of the intervention. SA 3: Prepare ORRS for dissemination.
Conditions
Interventions
- BEHAVIORAL
-
Opioid Rapid Resonse System (ORRS) training
ORRS is on online system to train citizen responders to administer NARCAN to save the lives of opioid overdose victims. It capitalizes on the innovative PulsePoint technology to connect responders to overdose events. PulsePoint is an app that connects 911 requesting assistance for cardiac arrests to responders with Cardiopulmonary Resuscitation (CPR) training. ORRS allows us to partner with PulsePoint users to expand its reach to opioid overdoses, which share the need for a quick response that emergency responders are often unable to provide. ORRS has the advantage of expanding the population of responders with NARCAN, rescue breathing, and CPR training that can be connected to overdose events, increasing the likelihood of saving overdose victims' lives through a quick, efficient response. ORRS is delivered through an interactive, digital platform containing sequential, multi-media modules.
- BEHAVIORAL
-
Non-active opioid overdose response training
Investigators will provide online training about opioid prevalence in US, opioid mechanism, side effect, and addiction. However, Investigators do not provide any knowledge about opioid overdose management and naloxone in this training. Once the project is completed, participants will receive online Naloxone training.
Sponsors & Collaborators
-
University of Missouri-Columbia
lead OTHER
Principal Investigators
-
Hye Jeong Choi · Univeristy of Missouri
-
Michael Hecht · Real Prevention
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-24
- Primary Completion
- 2025-12-29
- Completion
- 2025-12-29
Countries
- United States
Study Locations
More Related Trials
-
Naltrexone for Overdose Prevention
NCT06633900 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
NCT03337009 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA
-
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
NCT03821103 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2
NCT00000327 ·Status: WITHDRAWN ·Phase: PHASE2
-
Bioavailability of a New Formulation of Nasal Naloxone for Prehospital Use
NCT02158117 ·Status: COMPLETED ·Phase: PHASE1
-
Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics
NCT02662153 ·Status: COMPLETED
-
Surveillance Monitoring of Opioid Abuse in Poison and Drug Treatment Centers
NCT02871232 ·Status: UNKNOWN
-
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder
NCT04948307 ·Status: COMPLETED ·Phase: NA
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Pharmacokinetics and Pharmacodynamics of a New Formulation of Nasal Naloxone for Prehospital Use
NCT02307721 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Community Pharmacy-Based Prescription Drug Monitoring Program Opioid Risk Assessment Tool
NCT05706311 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
NCT06023459 ·Status: COMPLETED ·Phase: PHASE3
-
Nalox-Comm: Naloxone Communication Training for Pharmacists
NCT04677387 ·Status: COMPLETED ·Phase: NA
-
UnityPhilly Response App for Overdose Reversal
NCT06466005 ·Status: RECRUITING
-
Naloxone to TReatment Entry in the Emergency Setting
NCT03368794 ·Status: WITHDRAWN ·Phase: NA
-
Rapid Initiation of Drug Treatment Engagement
NCT03908437 ·Status: COMPLETED ·Phase: PHASE4
-
A Usability Assessment of Naloxone Administration by Untrained Community Members
NCT04025671 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine's Dose Response Curve
NCT00460239 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
NCT05011266 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1
NCT00078130 ·Status: COMPLETED ·Phase: PHASE3
-
Buprenorphine Naltrexone-P1 A-Cocaine
NCT00733720 ·Status: COMPLETED ·Phase: PHASE1
-
Oxycodone User Registry (OUR)
NCT00978328 ·Status: COMPLETED
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA